Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ZBIO will decline by -0.70% over the next 2 Weeks and hit $26.76 by Friday, October 9, 2026. In that time frame, ZBIO's share price is expected to range between $25.70 and $27.90.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 9, 2026 | 24.62 | 25.90 | 27.08 |
| Oct 8, 2026 | 24.37 | 25.66 | 26.92 |
| Oct 7, 2026 | 25.07 | 26.40 | 27.72 |
| Oct 6, 2026 | 25.74 | 27.00 | 28.36 |
| Oct 5, 2026 | 25.26 | 26.55 | 27.83 |
| Oct 2, 2026 | 25.08 | 26.42 | 27.75 |
| Oct 1, 2026 | 24.99 | 26.19 | 27.58 |
| Sep 30, 2026 | 25.67 | 26.93 | 28.25 |
| Sep 29, 2026 | 26.26 | 27.52 | 28.84 |
| Sep 28, 2026 | 25.84 | 27.08 | 28.31 |
ZBIO shares fell -2.00% in Friday, September 25, 2026's trading session, dropping from a previous close of $27.50 to move at $26.95. The stock demonstrated notable intraday movement (see ZBIO's key stats for a full breakdown), fluctuating between $25.90 and $28.50, a +10.04% trading range. While recent weeks have seen some volatility, ZBIO has managed to secure a -13.40% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 747.84K shares changing hands, 214.73K fewer than the previous session. This amounted to $20.15M in total market activity.
Will ZBIO Continue Its Upward Trend?
According to analyst ratings and projections for ZBIO, Zenas BioPharma, Inc. shares are anticipated to increase by +0.48%, potentially reaching $27.08 per share by October 9, 2026. Short-term technical indicators currently suggest a neutral sentiment for ZBIO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the ZBIO stock forecast, now is a good time to buy ZBIO stock because its current trading price is +4.06% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ZBIO covering social and institutional perspectives.
ZBIO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ZBIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 24.98% to 38.33%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 48.40%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.52%, maintains a neutral outlook for the long term. Insights into ZBIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Zenas BioPharma Short-Term Forecasts
ZBIO Forecast For Next 5 Days
Our algorithm anticipates Zenas BioPharma (ZBIO) stock could hit $26.69 by Oct 02, 2026. This represents a -0.98% rise from today's price, following a +5.56% change over the past five days.
ZBIO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Zenas BioPharma, Inc. (ZBIO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $25.50, which would mean a -5.38% decrease from the current price of $26.95. Projections for this period range from a high of $28.27 to a low of $22.54.
ZBIO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Zenas BioPharma's price over the next three months point to a rise. ZBIO stock is expected to peak at $43.68 on Nov 11, 2026 after potentially dipping to $23.38 on Nov 04, 2026. On average, ZBIO is likely to trade around $29.75 in the coming 90 days.
Zenas BioPharma Stock Forecast 2025
Based on our predictive models, Zenas BioPharma (ZBIO) is expected to trade between $23.38 and $43.68 throughout 2026. This would result in an average price of $29.81, potentially offering investors a +10.61% return from current levels.
Zenas BioPharma, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Zenas BioPharma, Inc. (ZBIO) is positioned to show a strong performance in September 2026. The price is predicted to move between $24.46 and $30.45, settling at an average of $27.62. This could translate to a +2.49% gain.
October 2026
Based on current market signals, Zenas BioPharma, Inc. is projected to trend october 2026. We forecast a trading range from $24.61 to $41.56, with a likely average price of $30.27. Investors could expect a potential return of +12.32%.
November 2026
Our predictive algorithms indicate Zenas BioPharma, Inc. stock may see a shift in November 2026. The expected range spans $23.38–$43.68, with an average target of $28.84. This represents a positive outlook and a possible gain of +7.01%.
December 2026
Analyzing established trends, Zenas BioPharma, Inc. looks set to move in December 2026. Projections place the stock between $26.87 and $34.01, averaging around $30.53. This suggests a +13.28% gain from current levels.
January 2027
Market indicators suggest Zenas BioPharma, Inc. could experience notable changes during January 2027. Prices could fluctuate within $27.90 to $35.39, with a midpoint forecast of $31.39. The stock might deliver a +16.47% gain.
February 2027
Forecasting for February 2027, models estimate that Zenas BioPharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $28.40 and $35.62, averaging $32.08. This signals a positive trajectory with potential returns around +19.04%.
March 2027
According to our latest forecast models, Zenas BioPharma, Inc. (ZBIO) is positioned to show a strong performance in March 2027. The price is predicted to move between $27.55 and $38.26, settling at an average of $33.87. This could translate to a +25.68% gain.
April 2027
Based on current market signals, Zenas BioPharma, Inc. is projected to trend april 2027. We forecast a trading range from $27.71 to $36.76, with a likely average price of $32.64. Investors could expect a potential return of +21.11%.
May 2027
Our predictive algorithms indicate Zenas BioPharma, Inc. stock may see a shift in May 2027. The expected range spans $31.56–$38.21, with an average target of $34.77. This represents a positive outlook and a possible gain of +29.02%.
June 2027
Analyzing established trends, Zenas BioPharma, Inc. looks set to move in June 2027. Projections place the stock between $32.21 and $39.27, averaging around $35.57. This suggests a +31.99% gain from current levels.
July 2027
Market indicators suggest Zenas BioPharma, Inc. could experience notable changes during July 2027. Prices could fluctuate within $32.26 to $40.25, with a midpoint forecast of $36.39. The stock might deliver a +35.03% gain.
August 2027
Forecasting for August 2027, models estimate that Zenas BioPharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $31.43 and $42.60, averaging $37.83. This signals a positive trajectory with potential returns around +40.37%.
September 2027
According to our latest forecast models, Zenas BioPharma, Inc. (ZBIO) is positioned to show a strong performance in September 2027. The price is predicted to move between $32.40 and $40.34, settling at an average of $36.87. This could translate to a +36.81% gain.
ZBIO's history of dividends and stock splits also plays a role in long-term investor confidence.

